WCM Investment Management LLC Purchases 347,984 Shares of DocGo Inc. (NASDAQ:DCGO)

WCM Investment Management LLC raised its holdings in DocGo Inc. (NASDAQ:DCGOFree Report) by 15.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,582,673 shares of the company’s stock after buying an additional 347,984 shares during the quarter. WCM Investment Management LLC owned 2.49% of DocGo worth $14,489,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Federated Hermes Inc. acquired a new position in DocGo in the third quarter worth about $29,000. Royal Bank of Canada lifted its position in shares of DocGo by 226.3% during the 1st quarter. Royal Bank of Canada now owns 3,263 shares of the company’s stock worth $30,000 after buying an additional 2,263 shares during the period. Tower Research Capital LLC TRC boosted its stake in DocGo by 145.6% in the 3rd quarter. Tower Research Capital LLC TRC now owns 5,908 shares of the company’s stock valued at $31,000 after buying an additional 3,502 shares in the last quarter. Wells Fargo & Company MN grew its position in DocGo by 320.1% in the fourth quarter. Wells Fargo & Company MN now owns 6,192 shares of the company’s stock valued at $44,000 after acquiring an additional 4,718 shares during the period. Finally, State of Wyoming acquired a new position in DocGo during the fourth quarter worth $50,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on DCGO shares. Canaccord Genuity Group reduced their target price on shares of DocGo from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Thursday. Needham & Company LLC decreased their price objective on shares of DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, February 29th. BTIG Research cut their target price on shares of DocGo from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday. Stifel Nicolaus cut their price objective on DocGo from $11.00 to $8.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, Cantor Fitzgerald decreased their target price on DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a report on Thursday, February 29th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, DocGo presently has a consensus rating of “Buy” and an average target price of $10.83.

Read Our Latest Research Report on DocGo

Insiders Place Their Bets

In other news, Director Michael J. Burdiek purchased 10,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were acquired at an average cost of $3.61 per share, for a total transaction of $36,100.00. Following the transaction, the director now directly owns 571,595 shares of the company’s stock, valued at approximately $2,063,457.95. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 13.78% of the company’s stock.

DocGo Stock Down 2.8 %

DCGO stock traded down $0.10 during midday trading on Friday, reaching $3.26. The stock had a trading volume of 1,058,818 shares, compared to its average volume of 948,899. DocGo Inc. has a twelve month low of $2.78 and a twelve month high of $10.82. The firm has a market cap of $339.59 million, a price-to-earnings ratio of 46.57, a PEG ratio of 0.33 and a beta of 0.91. The business has a fifty day simple moving average of $3.73 and a two-hundred day simple moving average of $4.70.

DocGo (NASDAQ:DCGOGet Free Report) last issued its earnings results on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.07). DocGo had a net margin of 1.10% and a return on equity of 2.01%. The business had revenue of $199.25 million for the quarter, compared to the consensus estimate of $195.48 million. On average, equities analysts predict that DocGo Inc. will post 0.35 earnings per share for the current fiscal year.

About DocGo

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Further Reading

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.